NCT00813202View on ClinicalTrials.gov

An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Heart DecompensationCongestive Heart Failure
Interventions
DRUG

Nesiritide

Nesiritide 0.01 mcg/kg/min intravenous (IV) infusion (with or without 2 mcg/kg bolus) for 24 to 168 hours (hrs)

Trial Locations (4)

Unknown

Beijing

Hangzhou

Shanghai

Xi'an

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT00813202 - An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure | Biotech Hunter | Biotech Hunter